ctDNA-based minimal residual disease detection in lung cancer patients treated with curative intended chemoradiotherapy using a clinically transferable approach

Background: Reliable biomarkers are needed to identify tumor recurrence of non-small cell lung cancer (NSCLC) patients after chemoradiotherapy (CRT) with curative intent. This could improve consolidation therapy of progressing patients. However, the approach of existing studies has limited transfera...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Lærke Rosenlund Nielsen, Simone Stensgaard, Peter Meldgaard, Boe Sandahl Sorensen
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2024-01-01
Saila:	Cancer Treatment and Research Communications
Gaiak:	NGS Biomarkers Liquid biopsies Time point Non-small cell lung cancer
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2468294224000145
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!